7YG3
Crystal structure of HLA-B*13:01
7YG3 の概要
エントリーDOI | 10.2210/pdb7yg3/pdb |
分子名称 | MHC class I antigen, Beta-2-microglobulin, ARG-GLN-ASP-ILE-LEU-ASP-LEU-TRP-ILE, ... (4 entities in total) |
機能のキーワード | hla-b*13:01, t cell receptor, drug-induced hypersensitivity syndrome, immune system |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 44886.88 |
構造登録者 | |
主引用文献 | Jiang, H.,Wang, C.W.,Wang, Z.,Dai, Y.,Zhu, Y.,Lee, Y.S.,Cao, Y.,Chung, W.H.,Ouyang, S.,Wang, H. Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity. J.Biomed.Sci., 29:58-58, 2022 Cited by PubMed Abstract: Severe cutaneous adverse drug reactions (SCARs) are a group of serious clinical conditions caused by immune reaction to certain drugs. The allelic variance of human leukocyte antigens of HLA-B*13:01 has been strongly associated with hypersensitivities induced by dapsone (DDS). T-cell receptor mediated activation of cytotoxic T lymphocytes (CTLs) has also been suggested to play an essential role in pathogenesis of SCARs. However, HLA-B*13:01-DDS-TCR immune synapse that plays role in drug-induced hypersensitivity syndrome (DIHS) associated T cells activation remains uncharacterized. PubMed: 35964029DOI: 10.1186/s12929-022-00845-8 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.5 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード